Since approval, the Food and Drug Administration has received additional reports of hematologic malignancies, including ...

Experience convenient blood cancer treatment close to home. Find out how this unique partnership brings autologous stem cell ...

The global Phase III VANCE trial of the autologous EBV-targeted T-cell therapy was the largest trial of a solid tumor cell ...

Roche's acquisition of Poseida Therapeutics (PSTX) for $1.5B joins the growing trend of cell therapies in M&A activities. Check out my review of this deal.

Despite challenges such as high attrition rates and adverse events, the trial highlights the value of established therapies ...

ADIA Med will particularly explore the use of Mesenchymal Stem Cells (MSCs), especially from Umbilical Cord sources, for ...

The following is a summary of “Autologous Peripheral Blood-Derived Orthobiologics for the Management of Shoulder Disorders: A ...

Medigene will slim its headcount by 40% and pause plans to get its first asset into the clinic in order to channel cash to ...

The Lehigh Valley Topper Cancer institute has announced that it is now offering treatment using autologous chimeric antigen ...

SCG has revealed late-breaking data outcomes from the Phase I clinical trial of autologous hepatitis B virus (HBV)-specific T ...

Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic ...